Product Images Guanfacine Extended-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Guanfacine Extended-release NDC 60505-3927 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure-1 - Figure 1
Figure-2 - Figure 2
Figure-3 - Figure 3
Figure4.jpg - Figure4
btl 1mg100s
This is a description of a medication called Guanfacine in extended-release tablets that contains 1mg of Guanfacine hydrochloride per tablet. The medication should be stored in a temperature-controlled environment and protected from moisture. The tablets should not be crushed or broken and it's recommended to dispense them in a tight container. The usual dosage information is available in the package insert. The medication is manufactured by Apotex Inc. in Toronto, Canada and manufactured for Apotex Corp. in Weston, Florida. *
btl 2mg100s
This is a description for a medication containing guanfacine hydrochloride in the form of extended-release tablets. Each tablet contains 2 mg of guanfacine. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from moisture. The tablets should be taken without crushing or chewing. The package insert should be consulted for the usual dosage. The medication is dispensed in a tight container by Apotex Corp, which also provides Patient Information at www1.apotex.com/products/us.*
btl 3mg100s
This is a description of a medication containing guanfacine hydrochloride in the form of an extended-release tablet. Each tablet contains 3 mg of guanfacine. The tablets should be stored at a temperature of 20°C to 25°C, with permitted excursions from 15°C to 30°C, and protected from moisture. The tablets should not be crushed, chewed, or broken before swallowing. The pharmacist should dispense the medication with patient information available at www1.apotex.com/products/us. The medication is manufactured by Apotex Inc in Toronto, Canada and is manufactured for Apotex Corp in Weston, Florida. The packaging consists of 100 tablets with NDC 60505-3929-1.*
btl 4mg100s
This is medication information for Guanfacine Extended-Release Tablets. Each tablet contains 4mg of guanfacine as guanfacine hydrochloride, and they should not be crushed or broken before swallowing. The tablets should be stored at 20°C to 25°C, with excursions permitted from 15°C to 30°C, and protected from moisture. Dispense in a tight container. The usual dosage is available in the package insert. The medication should be dispensed with patient information. Manufactured by Apotex Inc in Toronto, Ontario, Canada, and Manufactured for Apotex Corp in Weston, Florida.*
spd503-chemical-stucture - spd503 chemical stucture
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.